BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 1841036)

  • 1. Immunosuppressive activity of 15-deoxyspergualin (15-DOS) on various models of rheumatoid arthritis.
    Schorlemmer HU; Bartlett RR; Schleyerbach R; Seiler FR
    Drugs Exp Clin Res; 1991; 17(10-11):471-84. PubMed ID: 1841036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15-Deoxyspergualin (15-DOS) has a curative effect on the development of SLE-like autoimmune disease in MRL/1 mice.
    Schorlemmer HU; Bartlett RR; Seiler FR
    Agents Actions; 1991 Sep; 34(1-2):151-5. PubMed ID: 1793021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type II collagen-induced arthritis in the diabetic-resistant biobreeding rat: inflammatory and histopathological features of joint pathology and effects of antiinflammatory and antirheumatic drugs on this chronic arthritic process.
    Smith RJ; Sly LM
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1801-13. PubMed ID: 8667252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory cytokine levels in paw tissues during development of rat collagen-induced arthritis: effect of FK506, an inhibitor of T cell activation.
    Magari K; Miyata S; Ohkubo Y; Mutoh S
    Inflamm Res; 2004 Sep; 53(9):469-74. PubMed ID: 15551000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of joint disease in a rat model of collagen-induced arthritis by M40403, a superoxide dismutase mimetic.
    Salvemini D; Mazzon E; Dugo L; Serraino I; De Sarro A; Caputi AP; Cuzzocrea S
    Arthritis Rheum; 2001 Dec; 44(12):2909-21. PubMed ID: 11762952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel phosphoinositide 3-kinase δ,γ inhibitor: potent anti-inflammatory effects and joint protection in models of rheumatoid arthritis.
    Boyle DL; Kim HR; Topolewski K; Bartok B; Firestein GS
    J Pharmacol Exp Ther; 2014 Feb; 348(2):271-80. PubMed ID: 24244039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of lactosyl derivative Gu-4 in a collagen-induced arthritis rat model.
    Fan J; Zhou H; Wang S; Wang H; Zhang Y; Guo Y; Li Q; Li Z; Zhao Z
    Glycoconj J; 2012 Aug; 29(5-6):305-13. PubMed ID: 22688516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kirenol exerts a potent anti-arthritic effect in collagen-induced arthritis by modifying the T cells balance.
    Lu Y; Xiao J; Wu ZW; Wang ZM; Hu J; Fu HZ; Chen YY; Qian RQ
    Phytomedicine; 2012 Jul; 19(10):882-9. PubMed ID: 22673798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Petroleum ether extractive of the hips of Rosa multiflora ameliorates collagen-induced arthritis in rats.
    Wu J; Liu X; Chan CO; Mok DK; Chan SW; Yu Z; Chen S
    J Ethnopharmacol; 2014 Nov; 157():45-54. PubMed ID: 25256690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data.
    Bendele A; McAbee T; Sennello G; Frazier J; Chlipala E; McCabe D
    Arthritis Rheum; 1999 Mar; 42(3):498-506. PubMed ID: 10088773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longterm protection of mice against collagen-induced arthritis after short-term LF 15-0195 treatment: modulation of B and T lymphocyte activation.
    Ducoroy P; de Fornel D; Dubrez-Daloz L; Solary E; Dutartre P
    J Rheumatol; 2003 May; 30(5):918-25. PubMed ID: 12734883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oleuropein aglycone, an olive oil compound, ameliorates development of arthritis caused by injection of collagen type II in mice.
    Impellizzeri D; Esposito E; Mazzon E; Paterniti I; Di Paola R; Morittu VM; Procopio A; Britti D; Cuzzocrea S
    J Pharmacol Exp Ther; 2011 Dec; 339(3):859-69. PubMed ID: 21880869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-arthritic properties of FK506 on collagen-induced arthritis in rats.
    Magari K; Nishigaki F; Sasakawa T; Ogawa T; Miyata S; Ohkubo Y; Mutoh S; Goto T
    Inflamm Res; 2003 Dec; 52(12):524-9. PubMed ID: 14991082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of deoxyspergualin on collagen arthritis in mice.
    Takagishi K; Yamamoto M; Maeda K; Nishimura A; Yonemoto K; Hotokebuchi T; Kaibara N
    Clin Immunol Immunopathol; 1990 Jul; 56(1):81-7. PubMed ID: 2357860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of 15-deoxyspergualin in acute and chronic relapsing experimental allergic encephalomyelitis (EAE) as models for multiple sclerosis (MS).
    Schorlemmer HU; Seiler FR
    Drugs Exp Clin Res; 1991; 17(10-11):461-9. PubMed ID: 1841035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate ameliorates T cell dependent autoimmune arthritis and encephalomyelitis but not antibody induced or fibroblast induced arthritis.
    Lange F; Bajtner E; Rintisch C; Nandakumar KS; Sack U; Holmdahl R
    Ann Rheum Dis; 2005 Apr; 64(4):599-605. PubMed ID: 15345503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents.
    Lin HS; Hu CY; Chan HY; Liew YY; Huang HP; Lepescheux L; Bastianelli E; Baron R; Rawadi G; Clément-Lacroix P
    Br J Pharmacol; 2007 Apr; 150(7):862-72. PubMed ID: 17325656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topoisomerase II inhibitors, irrespective of their chemical composition, ameliorate experimental arthritis.
    Verdrengh M; Isaksson O; Tarkowski A
    Rheumatology (Oxford); 2005 Feb; 44(2):183-6. PubMed ID: 15494349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antiarthritic compounds on type II collagen-induced arthritis in rats.
    Probert AW; Schrier DJ; Gilbertsen RB
    Arch Int Pharmacodyn Ther; 1984 May; 269(1):167-76. PubMed ID: 6466005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.